tiprankstipranks
Abbott Laboratories (ABT)
NYSE:ABT
US Market
ABT
Abbott Laboratories
RESEARCH TOOLSreports
Want to see ABT full AI Analyst Report?

Abbott Laboratories (ABT) Ratios

9,086 Followers

Abbott Laboratories Ratios

ABT's free cash flow for Q4 2025 was $0.57. For the 2025 fiscal year, ABT's free cash flow was decreased by $ and operating cash flow was $0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.58 1.58 1.67 1.64 1.63
Quick Ratio
 1.18 1.18 1.23 1.16 1.23
Cash Ratio
 0.52 0.52 0.54 0.50 0.64
Solvency Ratio
 0.24 0.27 0.50 0.26 0.27
Operating Cash Flow Ratio
 0.58 0.58 0.60 0.52 0.62
Short-Term Operating Cash Flow Coverage
 2.89 2.89 4.88 5.48 3.86
Net Current Asset Value
$ -7.95B$ -7.95B$ -9.86B$ -11.72B$ -12.31B
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.17 0.19 0.22 0.24
Debt-to-Equity Ratio
 0.29 0.29 0.32 0.41 0.49
Debt-to-Capital Ratio
 0.22 0.22 0.24 0.29 0.33
Long-Term Debt-to-Capital Ratio
 0.17 0.17 0.21 0.26 0.28
Financial Leverage Ratio
 1.66 1.66 1.71 1.90 2.03
Debt Service Coverage Ratio
 2.50 2.63 7.31 4.78 3.76
Interest Coverage Ratio
 29.83 23.60 11.32 9.22 26.55
Debt to Market Cap
 0.09 0.06 0.07 0.08 0.09
Interest Debt Per Share
 8.78 8.82 9.17 9.56 10.42
Net Debt to EBITDA
 0.61 0.57 0.71 0.85 0.68
Profitability Margins
Gross Profit Margin
56.38%55.51%50.83%49.96%51.14%
EBIT Margin
19.53%19.87%18.15%18.35%19.75%
EBITDA Margin
23.94%26.06%25.83%26.44%27.23%
Operating Profit Margin
18.17%18.16%16.27%16.04%19.16%
Pretax Profit Margin
18.03%19.10%16.72%16.61%19.03%
Net Profit Margin
13.91%14.72%31.95%14.27%15.88%
Continuous Operations Profit Margin
13.91%14.72%31.95%14.27%15.88%
Net Income Per EBT
77.13%77.06%191.10%85.88%83.47%
EBT Per EBIT
99.21%105.19%102.75%103.56%99.33%
Return on Assets (ROA)
7.24%7.52%16.46%7.82%9.31%
Return on Equity (ROE)
12.40%12.51%28.12%14.83%18.90%
Return on Capital Employed (ROCE)
11.68%11.46%10.15%10.84%14.19%
Return on Invested Capital (ROIC)
8.60%8.43%9.89%9.10%11.36%
Return on Tangible Assets
10.98%11.42%25.94%14.05%16.83%
Earnings Yield
3.94%2.98%6.84%3.00%3.60%
Efficiency Ratios
Receivables Turnover
 5.69 5.59 6.06 6.11 7.02
Payables Turnover
 4.64 4.65 4.92 4.67 4.63
Inventory Turnover
 3.03 3.04 3.33 3.06 3.46
Fixed Asset Turnover
 3.49 3.43 3.58 3.56 4.25
Asset Turnover
 0.52 0.51 0.52 0.55 0.59
Working Capital Turnover Ratio
 4.57 4.67 4.58 4.32 4.18
Cash Conversion Cycle
 105.80 106.89 95.63 101.11 78.79
Days of Sales Outstanding
 64.12 65.29 60.25 59.74 51.99
Days of Inventory Outstanding
 120.28 120.08 109.62 119.47 105.63
Days of Payables Outstanding
 78.61 78.47 74.24 78.10 78.84
Operating Cycle
 184.40 185.37 169.87 179.22 157.62
Cash Flow Ratios
Operating Cash Flow Per Share
 5.48 5.48 4.94 4.19 5.47
Free Cash Flow Per Share
 4.23 4.23 3.67 2.92 4.45
CapEx Per Share
 1.24 1.24 1.27 1.27 1.01
Free Cash Flow to Operating Cash Flow
 0.77 0.77 0.74 0.70 0.81
Dividend Paid and CapEx Coverage Ratio
 1.52 1.52 1.42 1.26 1.88
Capital Expenditure Coverage Ratio
 4.41 4.41 3.88 3.30 5.39
Operating Cash Flow Coverage Ratio
 0.63 0.63 0.56 0.46 0.53
Operating Cash Flow to Sales Ratio
 0.21 0.22 0.20 0.18 0.22
Free Cash Flow Yield
4.67%3.38%3.24%2.65%4.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 25.37 33.55 14.62 33.35 27.76
Price-to-Sales (P/S) Ratio
 3.51 4.94 4.67 4.76 4.41
Price-to-Book (P/B) Ratio
 3.05 4.20 4.11 4.94 5.25
Price-to-Free Cash Flow (P/FCF) Ratio
 21.42 29.60 30.84 37.73 24.66
Price-to-Operating Cash Flow Ratio
 16.65 22.88 22.89 26.29 20.09
Price-to-Earnings Growth (PEG) Ratio
 -0.47 -0.65 0.11 -2.05 -36.74
Price-to-Fair Value
 3.05 4.20 4.11 4.94 5.25
Enterprise Value Multiple
 15.27 19.51 18.79 18.84 16.87
Enterprise Value
 164.93B 225.43B 203.53B 199.85B 200.53B
EV to EBITDA
 15.27 19.51 18.79 18.84 16.87
EV to Sales
 3.65 5.09 4.85 4.98 4.59
EV to Free Cash Flow
 22.30 30.48 32.05 39.50 25.70
EV to Operating Cash Flow
 17.24 23.57 23.78 27.52 20.93
Tangible Book Value Per Share
 13.29 13.29 10.48 3.65 2.08
Shareholders’ Equity Per Share
 29.84 29.84 27.52 22.26 20.93
Tax and Other Ratios
Effective Tax Rate
 0.23 0.23 -0.91 0.14 0.17
Revenue Per Share
 25.84 25.37 24.22 23.13 24.90
Net Income Per Share
 3.59 3.73 7.74 3.30 3.95
Tax Burden
 0.77 0.77 1.91 0.86 0.83
Interest Burden
 0.92 0.96 0.92 0.91 0.96
Research & Development to Revenue
 0.07 0.07 0.07 0.07 0.07
SG&A to Revenue
 0.28 0.28 0.28 0.00 0.00
Stock-Based Compensation to Revenue
 0.01 0.01 0.02 0.02 0.02
Income Quality
 1.47 1.47 0.64 1.27 1.38
Currency in USD